The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Otriflu 12.5mg Film-coated Tablets



GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/137/001

Main Information

Trade NameOtriflu 12.5mg Film-coated Tablets
Active SubstancesDiclofenac potassium
Dosage FormFilm-coated tablet
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/137/001

Group Information

ATC CodeM01AB Acetic acid derivatives and related substances
M01AB05 diclofenac

Status

License statusWithdrawn
Withdrawn Date19/12/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0057-021-003
Interchangeable List DocumentPDF of Interchangeable List
« Back